IBMS 2nd Joint Meeting of the International Bone & Mineral Society
Click here to go to the previous page
Apomab, a fully human agonistic DR5 monoclonal antibody inhibits tumour growth and osteolysis in murine models of breast cancer development and progression
Program Code:
300-2
Date:
Wednesday, March 25, 2009
Time:
11:00 AM to 12:00 PM
EST